Select a product:
Infectious disease
Bone and mineral metabolism
Endocrinology
Oncology
Liaison ®
Spq protein
Autoimmunity
Therapeutic drug monitoring
Cns
International Catalog
HEPATITIS - ELISA
Anti-HBs Quant AB AU Standard Set |
P001936 |
Intended use |
Standard Set anti-HBs (5-160 mIU/mL; WHO 1st Reference Preparation 1977) |
Sample type |
Serum/Plasma |
Comments |
ASR: Analyte Specific Reagent |
ETI-MAK-4 (HBsAg) |
N0019/192 Wells |
Intended use |
For the qualitative determination of Hepatitis B Surface Antigen (HBsAg). |
Label |
HRP |
Method |
ELISA |
Controls included |
Two Controls (positive, negative) |
Incubations |
30 min + 30 min/37°C, shaking or 1 h + 1 h/37°C |
Chromogen/Substrate |
TMB |
Feature & benefits |
Monoclonal Antibodies. |
Sample type |
Serum/Plasma |
Sample size |
100 µL |
HBsAg Confirmatory Test |
310110 |
Intended use |
For the confirmation of the presence of Hepatitis B Surface Antigen (HBsAg) in repeatedly reactive samples |
Material provided |
Reagent for 40 determinations to be used with ETI-MAK-4 |
Method |
Pretreatment of samples with anti-HBs reagent and specimen diluent followed by 2-step assay |
Incubations |
1h+ 1h/37°C |
Sample type |
Serum/Plasma |
Sample size |
300 µL |
ETI-AB-AUK-3 (anti-HBs) |
P001603/96 Wells |
Intended use |
For the qualitative/quantitative determination of Antibodies to Hepatitis B Surface Antigen (anti-HBs). |
Label |
HRP |
Method |
ELISA |
Controls included |
One Control (negative) |
Calibrators |
4 vials, from 10 to 1000 mIU/mL (WHO 1st International Reference Preparation, 1977) |
Incubations |
2 h + 1 h/37°C. |
Chromogen/Substrate |
TMB |
Sample type |
Serum/Plasma |
Sample size |
100 µL |
ETI-DELTAK-2 (HDAg) |
P002097/96 Wells |
Intended use |
For the qualitative determination of Hepatitis Delta Antigen (HDAg). |
Label |
HRP |
Method |
ELISA (Break |
Controls included |
Two Controls (positive, negative) |
Incubations |
1 h + 1 h/37°C |
Chromogen/Substrate |
TMB |
Feature & benefits |
Recombinant HDAg. |
Sample type |
Serum/Plasma |
Sample size |
100 µL |
ETI-AB-DELTAK-2 (anti-HDV) |
P2808/96 Wells |
Intended use |
For the qualitative determination of Total Antibodies to Hepatitis D Virus (anti-HDV). |
Label |
HRP |
Method |
ELISA |
Controls included |
Two Controls (positive, negative) |
Incubations |
3 h/37°C |
Chromogen/Substrate |
TMB |
Feature & benefits |
Recombinant HDAg. |
Sample type |
Serum/Plasma |
Sample size |
50 µL |
ETI-DELTAK-IGMK-2 (IgM anti-HDV) |
P001653/96 Wells |
Intended use |
For the qualitative determination of IgM Antibodies to Hepatitis D Virus (IgM anti-HDV). |
Label |
HRP |
Method |
ELISA |
Controls included |
Two Controls (positive, negative) |
Incubations |
1 h + 1 h + 1 h/37°C |
Chromogen/Substrate |
TMB |
Feature & benefits |
Recombinant HDAg, Human Chimeric anti-HD IgM, Monoclonal Antibody. |
Sample type |
Serum/Plasma |
Sample size |
100 µL (1:100 ) |
ETI-AB-COREK PLUS |
N0137/192 wells |
Intended use |
For the qualitative determination of Total Antibodies to Hepatitis B Virus Core Antigen (anti-HBc). |
Label |
HRP |
Method |
ELISA |
Controls included |
Two Controls (positive, negative) |
Calibrators |
1 vial |
Incubations |
2 h + 1 h/37°C |
Chromogen/Substrate |
TMB |
Sample type |
Serum/Plasma |
Sample size |
50 µL |
ETI-CORE-IgMK PLUS |
N0138/96 wells |
Intended use |
For the qualitative determination of IgM Antibodies to Hepatitis B Virus Core Antigen (IgM anti-HBc). |
Label |
HRP |
Method |
ELISA |
Controls included |
Two Controls (positive, negative) |
Calibrators |
1 vial |
Incubations |
2 h + 1 h/37°C |
Chromogen/Substrate |
TMB |
Feature & benefits |
Recombinant HBcAg |
Sample type |
Serum/Plasma |
Sample size |
100 µL (1:4000) |
ETI-EBK PLUS |
N0140/96 wells |
Intended use |
For the qualitative determination of Hepatitis B e Antigen (HBeAg). |
Label |
HRP |
Method |
ELISA |
Controls included |
Two Controls (positive, negative) |
Calibrators |
1 vial |
Incubations |
2 h + 1 h37°C +30 min/RT |
Chromogen/Substrate |
TMB |
Sample type |
Serum/Plasma |
Sample size |
50 µL |
ETI-AB-EBK PLUS |
N0139/96 wells |
Intended use |
For the qualitative determination of Antibodies to Hepatitis B e Antigen (anti-HBe). |
Label |
HRP |
Method |
ELISA |
Controls included |
Two Controls (positive, negative) |
Calibrators |
1 vial |
Incubations |
2 h + 1 h/37°C |
Chromogen/Substrate |
TMB |
Feature & benefits |
Recombinant HBeAg, Monoclonal Antibodies |
Sample type |
Serum/Plasma |
Sample size |
50 µL |
ETI-AB-HAVK PLUS |
N0136/96 wells |
Intended use |
For the qualitative/quantitative determination of total Antibodies to Hepatitis A Virus (anti-HAV) |
Label |
HRP |
Method |
ELISA |
Controls included |
Two Controls (positive, negative) |
Calibrators |
1 vial, 20 mIU/mL (WHO 2nd Int'l Standard,1998) |
Incubations |
2 h + 1 h/37°C |
Chromogen/Substrate |
TMB |
Sample type |
Serum/Plasma |
Sample size |
50 µL |
ETI-HA-IGMK PLUS |
N0142/96 wells |
Intended use |
For the qualitative determination of IgM Antibodies to Hepatits A Virus (IgM anti-HAV) |
Label |
HRP |
Method |
ELISA |
Controls included |
Two Controls (positive, negative) |
Calibrators |
1 vial |
Incubations |
2 h + 1 h/37°C |
Chromogen/Substrate |
TMB |
Sample type |
Serum/Plasma |
Sample size |
100 µL (1:100) |


